Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE Cell-Therapy Platform Toward First-in-Human Study
Collaboration supports IND-enabling development and a planned Phase 1/2a first-in-human clinical study…
Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year — New Study Challenges Notion the Tests are Interchangeable
Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces…
Bengaluru-based TerraTern Emerges As a Global Hub for AI-Powered Immigration, Work & Study Abroad Guidance
BANGALORE, India, March 17, 2026 /PRNewswire/ -- Since the advent of artificial…
Robot anxiety is highest where robots are least visible, new global study from Hexagon finds
A global split in confidence: UK adults are most anxious (52%) vs…
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
March 08, 2026 14:00 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
First Large-Scale Study by AI Search Monitoring Platform OtterlyAI Shows YouTube is #2 Social Platform for AI Citations
First analysis of 100 million AI citations across six platforms shows AI…
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful…
New Study Shows Americans Prefer Cold Filtered Water at HomeGlacier Fresh Responds With Coolon
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Americans’ relationship with drinking…
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
HAMILTON, ON, Feb. 24, 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a…
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX),…
